B. Hofer

发表

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease

M. Rudnicki, Johannes Leierer, P. Perco, 2021, International journal of molecular sciences.

Summary: Hypercapnia: Symptom or Protective Strategy?

B. Hofer, 1997 .

Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis

B. Hofer, M. Trauner, P. Schwabl, 2022, Hepatology communications.

"Cardiac arrest-Favorable functional outcome despite high NSE levels and early brain swelling".

B. Hofer, R. Beer, M. Joannidis, 2017, Resuscitation.

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.

J. Trebicka, S. Kubicek, B. Hofer, 2022, Journal of hepatology.

Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.

B. Hofer, M. Trauner, P. Schwabl, 2022, Advances in medical sciences.

Deviations From the Ideal Plasma Volume and Isolated Tricuspid Valve Surgery—Paving the Way for New Risk Stratification Parameters

B. Hofer, G. Laufer, D. Wiedemann, 2022, Frontiers in Cardiovascular Medicine.

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension

André F. Rendeiro, S. Kauschke, B. Hofer, 2023, bioRxiv.

Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis.

B. Hofer, M. Trauner, M. Mandorfer, 2022, Clinical Gastroenterology and Hepatology.

Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.

B. Hofer, B. Maasoumy, M. Mandorfer, 2024, Journal of hepatology.